ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 229 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,081,538 | +121.4% | 37,816 | +136.9% | 0.09% | +111.4% |
| Q4 2023 | $488,407 | +52.6% | 15,961 | +75.7% | 0.04% | -48.8% |
| Q2 2022 | $320,000 | -17.7% | 9,085 | -38.1% | 0.09% | -51.1% |
| Q2 2019 | $389,000 | +162.8% | 14,679 | +36.6% | 0.18% | +20.5% |
| Q4 2018 | $148,000 | – | 10,746 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |